PLOS ONE paper on cassava gene enhancement retracted

Sep 20, 2012 by Bob Yirka report
A manioc tuber. Manihot esculenta, also called yuca or casava. Credit: Wikipedia.

(Phys.org)—PLOS ONE, an open access peer review journal (launched in 2006) has issued a retraction regarding a paper it published recently touting the benefits of genetically enhanced cassava, saying that the results achieved by the research team could not be replicated and research materials used in the study could not be found.

is a root vegetable similar to the and is eaten in large quantities in the ; because of that research efforts have been undertaken to see if it can be made more nutritious. Over the past few years, some progress has been made, as new strains have been found to contain more vitamins and ways have been found to make it more resistant to viruses.

As a part of that effort, a research team from the Donald Danforth Plant Science Center, made up of members, Mohammad Abhary, Dimuth Siritunga, Gene Stevens, Nigel J. Taylor and Claude M. Fauquet submitted a paper to which was subsequently published, which described a technique for genetically altering cassava causing it to express the zeolin gene, resulting in a nutritional protein being produced. Unfortunately, the results achieved by the team could not be reproduced in subsequent tests led by team member Fauquet, and worse, specimens produced in the original study, upon new examination were found to not have the zeolin gene after all.

The original research was led by Abhary who has subsequently left the Center and now it appears suspicion has arisen suggesting he might have falsified documents or duped his colleagues into believing research had been conducted that had not occurred.

The retraction highlights a growing concern in the academic community regarding the integrity of papers published in though it does offer some optimism as well. Instead of trying to cover their mistakes, both the Danforth Center and PLOS ONE have been open and honest about the mistakes that were made and are apparently taking steps to prevent such an occurrence happening again.

Abhary, who has also left the country, has not commented on the or anything else since leaving the Center in the middle of last year, before suspicions arose. He'd been with the Center since 2006. Meanwhile, the Center says that the paper in question published in PLOS ONE, was the only one Abhary worked on, at least for Danforth. An internal investigation is continuing.

Explore further: Researchers demonstrate control of devastating cassava virus in Africa

More information: Transgenic Biofortification of the Starchy Staple Cassava (Manihot esculenta) Generates a Novel Sink for Protein, www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0016256

Related Stories

Super plants may fight African hunger

May 24, 2006

Ohio scientists say they've produced genetically modified cassava plants with roots more than two-and-a-half times the size of normal cassava roots.

Researchers complete draft genome sequence for cassava

Nov 09, 2009

A team of academic, government and industry researchers has completed a first draft of the cassava (Manihot esculenta) genome. The project is an important first step in accelerating the pace of research on this subsistence ...

Recommended for you

Gene discovery leads to new OPP test

Jun 18, 2013

The discovery of a gene associated with a persistent viral infection that causes an incurable disease—ovine progressive pneumonia (OPP)—in sheep has led to the development of a genetic test that can be ...

Genome sequence for mother of ash dieback survival

Jun 17, 2013

The first sequence data for a survivor of the ash dieback epidemic has been made available by scientists from The Genome Analysis Centre (TGAC) as part of a research collaboration led by the John Innes Centre and The Sainsbur ...

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

Squirrel
1 / 5 (2) Sep 20, 2012
The real problem is not outright faking (as here) but the misuse of "statistics" either unintentionally, intentionally or just-do-care-providing-we-can-get-published that "find" effects in real data that are not in fact there.
antialias_physorg
5 / 5 (2) Sep 20, 2012
Statistics are a problem - but not in the way you may think.

Peer review is pretty good at catching inconsistencies in statistics. What is sometimes harder to detect is whether the right statistical measures were used (because the selection process is usually not part of the paper) .

It's very hard to determine the right statistical tests. And the right tests for the tests. And the right tests for the tests for the tests.
I'm not kidding. There are at least 3 levels of testing for applicability you have to go through to even determine which statistical model is right for your data. (Not that the others will give you a completely wrong result. They might if your data distribution is 'unfortunate')

It's very easy to make a mistake - and against all impression not every scientist is an expert in all of science (few are experts in statistics).

The number of tests available are just huge - and I have yet to see the person who can understand/delineate between them all correctly.

More news stories

Surprise species at risk from climate change

(Phys.org) —Most species at greatest risk from climate change are not currently conservation priorities, according to an International Union for Conservation of Nature (IUCN) study that has introduced a ...

Tech companies eye security that goes beyond passwords

In late February, a thief or thieves cracked into Evernote's digital vault filled with log-ins, passwords and email addresses belonging to 50 million users. It was a shocking cyberattack considering the Redwood City, Calif., ...

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...

No danger of cancer through gene therapy virus

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...